Glenmark Pharmaceuticals ,Hikma enter join hands for commercializing Ryaltris™ Seasonal Allergic Rhinitis Nasal Spray in US Medical Dialogues Bureau28 Feb 2020 9:12 AM GMTRyaltris™ [olopatadine hydrochloride (665 mcg) and mometasone furoate (25 mcg)], developed by Glenmark, is a novel fixed-dose combination nasal spray...
GSK receives USFDA panel backing for OTC nicotine oral spray for smoking de-addiction Farhat Nasim19 Sep 2019 4:00 AM GMTJohnson & Johnson (JnJ), GSK Plc's developmental partner, sell the over-the-counter nicotine oral spray in 45 countries, excluding the United...
USFDA nod to Teva generic nasal spray-Narcan to treat opioid overdose Medical Dialogues Bureau21 April 2019 3:57 AM GMTThe U.S. Food and Drug Administration granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a...
Glenmark completes phase 3 study for nasal spray Ruby Khatun Khatun15 Dec 2017 4:45 AM GMTNew Delhi: Glenmark Pharmaceuticals said it has completed phase 3 study of its investigational fixed-dose combination nasal spray and plans to submit...
Zydus gets USFDA nod to market anti-diuretic nasal spray Ruby Khatun Khatun5 Oct 2017 4:47 AM GMTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market anti-diuretic Desmopressin nasal spray...
